2Li CF, Shen KH, Huang LC, et aI. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma[J]. Pathology, 2010,42 (1) :43-49.
3Schmidbauer J, Remzi M, Klatte T, et al. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder[J]. Eur Urol, 2009,56 (6) : 914-919.
4Gupta NP, Sharma N, Kumar R. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder[J]. Urology, 2009,73 (3) : 592-596.
6C, hen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascula Fproliferative disorders[J]. Nat Cell Bid, 2004,6(9) :872-883.
7Hofmann WK, Takeuchi S, Xie D, ctal. Frequent loss of het- erozygo-sity in the region of D1 $450 at lp36,2 in myelidysplastic syndromes[ J]. Leuk Res, 2001,25 (5) :855-858.
8Rojo M, Legres F, Chateau D, et al. Membrane topology andmito- chondrial targeting ofmitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo [ J ]. Cell Sci, 2002, 115 ( 8 ) : 1663-1674.
9Eura Y, Ishihara N, Yokota S, et al. Twomitofusin proteins, mam- malian homologues of FZO, with distinct functions are both re- quired formitochondrial fusion [ J]. J Biochem, 2003,134 ( 3 ) : 333-344.
10Chen KH, Guo XM, Ma DL, et al. Dysregulation of HSG triggers vascular proliferative disorders [J]. Nat Cell Biol, 2004,6 (9) : 872-883.
